Repurposed Drug Interferon for the Treatment of Polycythemia Vera

Drug Gives Woman with Polycythemia Vera – Blood Cancer the Gift of Life

This patient story was featured on ABC 7, Chicago News.  It is encouraging to see MPN patients share their story on the local TV news media.  The MPN Research Foundation also covered Karrie’s story in their latest newsletter.  I wish more patients would step forward and share their story with local news media channels.  This is a wonderful opportunity to increase MPN awareness and gain more support for our illness.  I will be doing the same in a local newspaper in July 2018.

Interferon is an off-label (repurposed) medication that is currently the only treatment to provide MPN altering effects for many patients (approximately 70%), while other patients may experience toxicities or little benefit.

Here is Karrie’s Story:


About David Wallace

Founder of PV Reporter, a resource for Myeloproliferative Neoplasm (MPN) patients and caregivers. After being diagnosed with Polycythemia Vera (PV) in 2009, I utilized social media to connect with "informed patients" and develop a better understanding of emerging treatment options. My philosophy on patient care is straight forward - "educating the patient is essential, so the patient can guide their physician to meet his or her needs." PV Reporter is a comprehensive resource hub giving visitors vital tools to become "empowered patients."

error: Content is protected !